JPMorgan Cuts Swiss Re Rating, Sees Softer Market Outlook

JPMorgan lowered its rating on Swiss Re this week, moving the stock to Neutral from Overweight and trimming its price target to CHF 160 from CHF 170.

The bank told investors in a note that the downgrade reflects both valuation concerns and signs of ongoing weakness in the reinsurance market.

Analysts at JPMorgan cautioned that the pricing environment for reinsurers is set to soften further into 2026, marking the second consecutive year of decline. The firm argued that Swiss Re’s valuation had become stretched relative to peers, leaving limited upside for investors at current levels.

WELCOME BONUS - Free Share Bundle When You Invest £50! Get up to £500 cashback for investing with IG.

Invest in 15,000+ shares and ETFs. Open an account now, invest at least £50, and you’ll get a free share bundle worth between £40 and £200. T&Cs apply.

5.0

Open Account Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 68% of retail investor accounts lose money when trading spread bets and CFDs with this provider. You should consider whether you understand how spread bets and CFDs work, and whether you can afford to take the high risk of losing your money.

The downgrade follows a series of similar moves from other banks in recent months. In June, both Morgan Stanley and Barclays cut Swiss Re to Underweight, citing its exposure to a weakening market backdrop and stretched valuations across the sector.

Reinsurers had benefited from strong pricing in recent years amid rising natural catastrophe claims and inflation-linked adjustments. However, analysts now see that momentum is fading, with competitive pressures and moderating demand weighing on premium growth.

Barclays said in its note that consensus positioning around large-cap European insurance sector proxies “leaves valuations relatively full at a time when the scope for earnings surprises is running out of steam.”

Shares in Swiss Re have gained year-to-date, up around 8.6%, supported by resilient earnings, but JPMorgan’s note suggests investors should temper expectations.